Original language | English (US) |
---|---|
Pages (from-to) | 9-19 |
Number of pages | 11 |
Journal | Pain |
Volume | 113 |
Issue number | 1-2 |
DOIs | |
State | Published - Jan 2005 |
Keywords
- Adverse events
- Assessment
- Chronic pain
- Clinical trials
- Emotional functioning
- Global ratings
- Health-related quality of life
- Outcomes
- Physical functioning
- Randomized controlled trials
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
- Anesthesiology and Pain Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Core outcome measures for chronic pain clinical trials : IMMPACT recommendations. / Dworkin, Robert H.; Turk, Dennis C.; Farrar, John T.; Haythornthwaite, Jennifer A.; Jensen, Mark P.; Katz, Nathaniel P.; Kerns, Robert D.; Stucki, Gerold; Allen, Robert R.; Bellamy, Nicholas; Carr, Daniel B.; Chandler, Julie; Cowan, Penney; Dionne, Raymond; Galer, Bradley S.; Hertz, Sharon; Jadad, Alejandro R.; Kramer, Lynn D.; Manning, Donald C.; Martin, Susan; McCormick, Cynthia G.; McDermott, Michael P.; McGrath, Patrick; Quessy, Steve; Rappaport, Bob A.; Robbins, Wendye; Robinson, James P.; Rothman, Margaret; Royal, Mike A.; Simon, Lee; Stauffer, Joseph W.; Stein, Wendy; Tollett, Jane; Wernicke, Joachim; Witter, James.
In: Pain, Vol. 113, No. 1-2, 01.2005, p. 9-19.Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Core outcome measures for chronic pain clinical trials
T2 - IMMPACT recommendations
AU - Dworkin, Robert H.
AU - Turk, Dennis C.
AU - Farrar, John T.
AU - Haythornthwaite, Jennifer A.
AU - Jensen, Mark P.
AU - Katz, Nathaniel P.
AU - Kerns, Robert D.
AU - Stucki, Gerold
AU - Allen, Robert R.
AU - Bellamy, Nicholas
AU - Carr, Daniel B.
AU - Chandler, Julie
AU - Cowan, Penney
AU - Dionne, Raymond
AU - Galer, Bradley S.
AU - Hertz, Sharon
AU - Jadad, Alejandro R.
AU - Kramer, Lynn D.
AU - Manning, Donald C.
AU - Martin, Susan
AU - McCormick, Cynthia G.
AU - McDermott, Michael P.
AU - McGrath, Patrick
AU - Quessy, Steve
AU - Rappaport, Bob A.
AU - Robbins, Wendye
AU - Robinson, James P.
AU - Rothman, Margaret
AU - Royal, Mike A.
AU - Simon, Lee
AU - Stauffer, Joseph W.
AU - Stein, Wendy
AU - Tollett, Jane
AU - Wernicke, Joachim
AU - Witter, James
N1 - Funding Information: The authors thank Charles S. Cleeland, PhD, for his comments on a preliminary draft of this article, and Paul J. Lambiase and Mary Gleichauf for their invaluable assistance. Abbott Laboratories, AstraZeneca, Elan Pharmaceuticals, Eli Lilly & Co., Endo Pharmaceuticals Inc., GlaxoSmithKline, Johnson and Johnson, Merck & Co., NeurogesX, Novartis Pharmaceuticals, Pfizer, and Purdue Pharma provided unrestricted grants to the University of Rochester Office of Professional Education to support the consensus meeting.
PY - 2005/1
Y1 - 2005/1
KW - Adverse events
KW - Assessment
KW - Chronic pain
KW - Clinical trials
KW - Emotional functioning
KW - Global ratings
KW - Health-related quality of life
KW - Outcomes
KW - Physical functioning
KW - Randomized controlled trials
UR - http://www.scopus.com/inward/record.url?scp=19944381491&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19944381491&partnerID=8YFLogxK
U2 - 10.1016/j.pain.2004.09.012
DO - 10.1016/j.pain.2004.09.012
M3 - Review article
C2 - 15621359
AN - SCOPUS:19944381491
VL - 113
SP - 9
EP - 19
JO - Pain
JF - Pain
SN - 0304-3959
IS - 1-2
ER -